Zoetis, Pfizer’s Animal Health Spin-Off (B) Harvard Case Solution & Analysis

This case illustrates different growth strategies in the pharmaceutical business. Is management R&D a crucial element of growth strategies, the case illustrates the value of using a holistic framework for R&D when enlarging the firm's company footprint.

Zoetis, Pfizer’s Animal Health Spin-Off (B) Harvard Case Solution & Analysis

The case serves the intent of identifying the steps that are crucial for the performance of these strategies, and comparing organic and inorganic growth strategies.

PUBLICATION DATE: August 21, 2015 PRODUCT #: IN1092-HCB-ENG

This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE

Zoetis, Pfizer’s Animal Health Spin-Off (B) Case Solution Other Similar Case Solutions like

Zoetis, Pfizer’s Animal Health Spin-Off (B)

Share This